The trials that support it were conducted in a population with a specific metabolic condition, and generalizing those results to general obesity is not straightforward
The Weight Loss Benefits of Ozempic Ozempic has shown significant weight loss results in clinical studies
The dose and duration-dependent association between melatonin treatment and overall cognition in Alzheimers dementia: a network meta- analysis of randomized placebo-controlled trials
Reporting side effects to healthcare providers is critical
GCGR agonism: Acts on glucagon receptors, promotes fat decomposition, accelerates energy consumption, and at a specific dose can regulate liver glycogen metabolism to avoid the risk of hypoglycemia

Retatrutide shows potential for greater efficacy through triple-agonism but awaits Phase 3 results Best For Recommendations# Currently Available Treatment# Recommendation : Tirzepatide Reason : FDA-approved and commercially available as Mounjaro/Zepbound with established dosing protocols and post-market safety data Maximum Weight Loss Potential# Recommendation : Retatrutide Reason : Phase 2 data showed 24.2% weight loss at 48 weeks, exceeding tirzepatide's results, though Phase 3 confirmation is pending Non-Alcoholic Fatty Liver Disease# Recommendation : Retatrutide Reason : Glucagon receptor agonism directly promotes hepatic fat oxidation, showing up to 82% liver fat reduction in trials Type 2 Diabetes Management# Recommendation : Tirzepatide Reason : Proven HbA1c reduction with FDA approval specifically for glycemic control in type 2 diabetes Further Reading# Which Is Better For